文献速递糖尿病肥胖与代谢综合征

Look AHEAD研究中结构化生活方式干预在超重/肥胖2型糖尿病成人中的试验内成本效果

Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study.
PubMed 文献 · Diabetes Care · 2020-11-09

基于Look AHEAD研究4,827名超重/肥胖2型糖尿病成人前9年数据,比较强化生活方式干预(ILI)与标准糖尿病支持教育(DSE)的成本效果。ILI人均累计干预成本11,275美元、医疗支出64,453美元,DSE分别为887美元和68,174美元,ILI人均多花费6,666美元。增量成本效果比因效用指标不同而异,从HUI无健康获益且成本更高,到SF-6D的96,458美元/QALY和FT的43,169美元/QALY,成本效果尚不明确。

要点

  • ILI较DSE人均多花费6,666美元(2012年美元)。
  • SF-6D和FT显示ILI获得额外QALY,但HUI未显示统计学显著获益。
  • ICER从HUI的无健康获益且成本更高到SF-6D的96,458美元/QALY、FT的43,169美元/QALY。

核心结论

  • ILI在9年期间是否具有成本效果尚不明确,因不同健康效用指标得出不同结论。

研究设计与样本

  • 基于Action for Health in Diabetes(Look AHEAD)研究,纳入4,827名超重/肥胖2型糖尿病成人,分析2001至2012年前9年数据。
  • 比较强化生活方式干预(ILI)与标准糖尿病支持教育(DSE),测量增量成本效果比(ICER),未来成本和QALY按每年3%贴现,成本为2012年美元。

主要发现

  • 9年间ILI组人均累计干预成本11,275美元、累计医疗支出64,453美元;DSE组分别为887美元和68,174美元。
  • ILI较DSE人均多花费6,666美元。
  • ILI获得的额外QALY经HUI-2和HUI-3测量无统计学显著性,经SF-6D和FT测量分别为0.07和0.15。

关键数值与推荐

  • ICER基于HUI为无健康获益且成本更高,基于SF-6D为96,458美元/QALY,基于FT为43,169美元/QALY。

临床怎么用

  • 临床决策中需注意不同健康效用指标对成本效果结论的影响,ILI的成本效果尚不确定。

局限性

  • 成本效果结论因健康效用测量工具不同而不一致,9年试验内结果可能无法外推至更长周期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the cost-effectiveness (CE) of an intensive lifestyle intervention (ILI) compared with standard diabetes support and education (DSE) in adults with overweight/obesity and type 2 diabetes, as implemented in the Action for Health in Diabetes study. RESEARCH DESIGN AND METHODS: Data were from 4,827 participants during their first 9 years of study participation from 2001 to 2012. Information on Health Utilities Index Mark 2 (HUI-2) and HUI-3, Short-Form 6D (SF-6D), and Feeling Thermometer (FT), cost of delivering the interventions, and health expenditures was collected during the study. CE was measured by incremental CE ratios (ICERs) in costs per quality-adjusted life year (QALY). Future costs and QALYs were discounted at 3% annually. Costs were in 2012 U.S. dollars. RESULTS: Over the 9 years studied, the mean cumulative intervention costs and mean cumulative health care expenditures were $11,275 and $64,453 per person for ILI and $887 and $68,174 for DSE. Thus, ILI cost $6,666 more per person than DSE. Additional QALYs gained by ILI were not statistically significant measured by the HUIs and were 0.07 and 0.15, respectively, measured by SF-6D and FT. The ICERs ranged from no health benefit with a higher cost based on HUIs to $96,458/QALY and $43,169/QALY, respectively, based on SF-6D and FT. CONCLUSIONS: Whether ILI was cost-effective over the 9-year period is unclear because different health utility measures led to different conclusions.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhang P, Atkinson KM, Bray GA, et al. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. Diabetes Care. 2020. PMID: 33168654. doi:10.2337/dc20-0358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。